Atlas Trials

A Phase II Study Evaluating the Efficacy and Safety of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Clinical trial NCT06978699 · RECRUITING

Trial details

NCT number
NCT06978699
Sponsor
S-INFINITY Pharmaceuticals Co., Ltd
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
PNH - Paroxysmal Nocturnal Hemoglobinuria
Start date
2025-04-30
Primary completion
2025-08-30
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.